Yes Maldowl
An extract below
"CGP’s strategy is to identify, acquire and commercialise under-valued late stage therapeutic delivery technologies in high value markets and indications, using an acquisition strategy driven by strategic value creation, patent protection and realization criteria."
cap raising, page-45
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 104978 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 7500 | 1 |
View Market Depth
| Last trade - 16.12pm 07/08/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable